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Background. Telemedicine use is increasing in many specialties, but its impact on clinical outcomes in infectious diseases has
not been systematically reviewed. We reviewed the current evidence for clinical effectiveness of telemedicine infectious diseases
consultations, including outcomes of mortality, hospital readmission, antimicrobial use, cost, length of stay, adherence, and patient
satisfaction.
Methods. We queried Ovid MEDLINE 1946-, Embase.com 1947-, Scopus 1823-, Cochrane Database of Systematic Reviews
(CDSR), Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov 1997- through August 5, 2019, for
studies looking at clinical outcomes of infectious diseases in the setting of telemedicine use. We did not restrict by language or year
of publication. Clinical outcomes searched included 30-day all-cause mortality, 30-day readmissions, patient compliance/adherence,
patient satisfaction, cost or cost-effectiveness, length of hospital stay, antimicrobial use, and antimicrobial stewardship. Bias was assessed using standard methodologies. PROSPERO CRD42018105225.
Results. From a search pool of 1154 studies, only 18 involved telemedicine infectious diseases consultation and our selected clinical
outcomes. The outcomes tracked were heterogeneous, precluding meta-analysis, and the majority of studies were of poor quality. Overall,
clinical outcomes with telemedicine infectious diseases consultation seem comparable to in-person infectious diseases consultation.
Conclusions. Although in widespread use, the clinical effectiveness of telemedicine infectious diseases consultations has yet to
be sufficiently studied. Further studies, or publication of previously collected and available data, are warranted to verify the cost-effectiveness of this widespread practice.
Keywords. clinical outcomes; infectious diseases consultation; mortality; systematic review; telemedicine.
Systematic review registration.

PROSPERO CRD42018105225.

According to recent estimates, infectious diseases may be the
third leading cause of death in the United States [1]. However,
underserved and/or economically disadvantaged areas may not
have access to infectious diseases (ID) physicians (up to 45% of
US hospitals) to help treat these infections [2]. This is problematic because consultation with ID physicians significantly reduces mortality for numerous infections [3, 4]. Providing access
to ID expertise in underserved/rural areas could substantially
reduce mortality and improve clinical outcomes. As 51% of ID
fellowship programs did not fill in 2015 [5, 6], access to ID expertise may be limited. With a shortage of ID physicians, it may
not be possible for remote locations to employ an ID physician,
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that is, what is seen in current practice. Telemedicine could potentially expand ID expertise to underserved areas.
Telemedicine is widely used in many subspecialties. Studies
show that telemedicine reduces mortality in progressive and intensive care units and in very low birth weight infants [7–9],
but its effectiveness for important clinical outcomes in infectious diseases is lacking. To date, there has been no synthesis
of evidence for the use of telemedicine for infectious diseases
consultation. Our systematic review addresses this deficiency
by answering the following question: In patients with infectious
diseases, do telemedicine ID consultations improve the clinical
outcomes of mortality, readmission, patient adherence/compliance, patient satisfaction, cost, cost-effectiveness, length of stay,
antibiotic use, or antibiotic stewardship?
METHODS
Data Sources and Searches

A medical librarian (L.H.Y.) searched the literature for records including the concepts of infectious diseases, infection,
antimicrobial stewardship, antibiotic stewardship, antifungal
stewardship, antiviral stewardship, telemedicine and videoconferencing, and consultation/consult. The librarian created search
Telemedicine ID Consultation • ofid • 1

Downloaded from https://academic.oup.com/ofid/article-abstract/6/12/ofz517/5658639 by Washington University at St Louis user on 04 January 2020

Telemedicine Infectious Diseases Consultations and
Clinical Outcomes: A Systematic Review

Reasons to exclude:
no infections, no consultations, consultations
not for infection, no telemedicine, noninterventional study, infectious diseases
outcomes indistinguishable from those of other
consultations, no outcomes of interest tracked

Titles/abstracts
screened
(n = 1155)

Records
excluded
(n = 1138)

Aim

Our goal was to assess the effectiveness of telemedicine ID consultation for a range of clinical outcomes (enumerated below) as
compared with either (1) no ID consultation or (2) other modalities of ID consultation (eg, in person). Clinical outcomes considered included 30-day all-cause mortality, readmission within
30 days of discharge from an initial hospitalization with an infection, patient compliance/adherence, patient satisfaction, cost
or cost-effectiveness, length of hospital stay, antimicrobial use,
and/or antimicrobial stewardship.
There were no language or year of publication restrictions.
Translation of non-English-language abstracts was undertaken, as required, though ultimately all full-text articles were
in English. Conference abstracts were excluded if sufficient outcome and bias data could not be extracted. REDCap was used
for data entry.

Full-text articles
reviewed in depth
(n = 17)

Reviewed
references of
unique studies for
additional studies
(n = 1)

Unique studies
included in final
qualitative
synthesis
(n = 18)

Study Selection

After removal of duplicate results, titles and abstracts were reviewed for relevance to the research question by J.P.B. See
Figure 1 for the study flowchart from title/abstract review to final
inclusion. Articles were excluded if any of the following conditions was met: (1) infections not studied, (2) no consultations, (3)
consultations not performed for infection, (4) no telemedicine,
(5) noninterventional (eg, viewpoint articles, commentaries,
etc.), (6) infectious diseases outcomes indistinguishable from
other consultations, (7) no prespecified outcomes of interest
tracked, or (8) abstract only with insufficient methodological or
results reporting. Studies that were not excluded underwent independent, blinded, full-text review by J.P.B. and G.A.C.

Figure 1. Flowchart for systematic review.

Data Extraction

In a blinded fashion, 2 authors (J.P.B. and G.A.C.) independently extracted data from full-text articles. Data extracted included study quality, clinical or system-level outcome tracked,
percent change or proportion experiencing each clinical outcome, numbers of patients, age group, consultant specialty, type
of telemedicine, study location, whether infection was confirmed by laboratory results, and type and risk of bias.
Data extraction disputes were settled by a third reviewer
(S.A.F.—also blinded), and in cases requiring further adjudication, a group session of all 3 reviewers was convened.

Definitions

Telemedicine was defined as remote clinical services administered using a technological medium. This included face-to-face
video chat (physician-to-physician or physician-to-patient),
voice chat after review of electronic health records, or electronic health record documentation after remote chart review
without direct voice or video contact with physician or patient.
Antibiotic stewardship was quantified as either antibiotic costs
or antibiotic appropriateness, as judged by the authors of the
individual studies.
2 • ofid • Burnham et al

Quality Assessment

Risk of bias was independently reviewed by 2 reviewers
(J.P.B. and G.A.C.) in a blinded fashion. Disputes were resolved
by a third reviewer (S.A.F.—also blinded), and in cases of continued disagreement, the 3 reviewers met for adjudication.
Bias determination was guided by the Cochrane Consumers
and Communication Review Group Study Quality Guide or
Newcastle-Ottawa scale [12, 13]. Using the Newcastle-Ottawa
Scale, the case–control and cohort studies were given star ratings
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strategies using a combination of keywords and controlled vocabulary in Ovid Medline 1946-, Embase 1947-, Scopus 1823-,
Cochrane Database of Systematic Reviews (CDSR), Cochrane
Central Register of Controlled Trials (CENTRAL), and
Clinicaltrials.gov 1997-. All search strategies were completed
in November 2018, then updated in August 2019. The protocol
was registered with the international prospective register of systematic reviews (PROSPERO), in accordance with PRISMA-P
guidelines (PROSPERO CRD42018105225) [10]. The protocol
for this systematic review has been previously described [11].

Analysis

Per protocol [11], prespecified subgroup analyses included
outcomes by age (children <18 years vs adult ≥18 years), telemedicine consultant being ID trained or not, infection type,
type of telehealth/telemedicine intervention (eg, face-to-face,
asynchronous, etc.), study location (US vs non-US), number
of ID consultations (ie, days physician interacted with patient/
provider), and culture- or laboratory-confirmed infection vs
presumed infection. Due to the limited number of studies, qualitative/narrative synthesis was performed.

Scale, both the case–control studies and 8 cohort studies were
rated as poor quality. The remaining 6 cohort studies were rated
as good quality (Supplementary Table 2).
Study Characteristics

Most studies were performed only in adults (n = 13, 72.2%).
Consultant specialty was infectious diseases in only 38.9%
(n = 7). Infections studied included pneumonia (n = 4), urinary
tract infection (n = 5), sepsis (n = 3), bacteremia (n = 3), endocarditis (n = 2), skin and soft tissue infections (n = 3), upper
respiratory infections (n = 4), and other (n = 12). More than 1
infection type could be studied in each article.
The most common type of telemedicine was face-to-face videoconferencing with the patient in 72.2% (n = 13), followed
by telephone only (16.7%, n = 3), physician-to-physician only
(5.6%, n = 1), and 1 study in which the telemedicine type could
not definitively be determined.
Just over half (n = 10) were based in the United States,
and 8 in other countries (Europe = 4, Australia = 2, Asia = 1,
Canada = 1). Infections were confirmed by culture in 61.1%
(n = 11) of studies.

RESULTS

A total of 1328 results were found using our initial search
strategy, which was completed in November 2018. A total of
284 duplicate records were identified using Endnote’s automatic
duplication finder, and another 31 duplicates were removed by
manual review, leaving 1013 unique citations in the project library. One additional study was identified after reviewing references of full-text article reviews, for a total of 1014 search
results. We updated our search on August 5, 2019. With this
update, an additional 140 results were found, leaving a total of
1154 results to be reviewed. Fully reportable searches can be
found in Appendix 1.
Of the 1154, none of the clinical trials identified only from
ClinicalTrials.gov (n = 21) had available results. Of the remaining excluded articles, the reasons for exclusion are listed in
Figure 1 and Supplementary Table 1. A total of 18 articles were
relevant to the research question and underwent full-text review.
From these articles, clinical outcomes tracked included 30-day
mortality after an infection (16.7%, n = 3), readmission within
30 days after discharge from the initial hospitalization with an
infection (5.6%, n = 1), patient compliance/adherence (11.1%,
n = 2), patient satisfaction (50.0%, n = 9), cost or cost-effectiveness (22.2%, n = 4), length of stay (27.8%, n = 5), and antimicrobial use (27.8%, n = 5). Meta-analysis was not performed due to
the low number of studies with any 1 outcome.
Biases/Quality Assessment

There were 2 (11.1%) randomized clinical trials, 2 case–control
studies (11.1%), and 14 (77.8%) cohort studies. Both randomized controlled trials had high risk of bias in 3 categories and
unclear risk in 2 others [15, 16]. Using the Newcastle-Ottawa

Clinical Outcomes

Patient satisfaction with telemedicine was the most commonly
reported outcome, and the percentage of patients satisfied
with telemedicine was above 97% in 6/7 studies [17–22], with
1 study reporting patient satisfaction of 69% (Table 1) [16].
Two additional studies reported patient satisfaction but provided a mean satisfaction score without a numerator and denominator for the number of patients reporting the outcome,
though the mean score in both studies was indicative of high
satisfaction [23, 24].
Mortality was higher in the telemedicine group in 2 studies
and lower in the other 2 studies reporting this outcome (range
for all studies, 0%–22%) [15, 25–27], with 1 study reporting
90-day instead of 30-day mortality (higher mortality in the
control group) (Table 1) [27]. Only 1 of these studies was statistically significant, with lower mortality in patients receiving
in-person rather than telephone-only ID consults [26]. Length
of stay was shorter in the telemedicine group in 4/5 studies
[24–27] and equivalent in 1 study (range, 2.6–30 days) (Table
1) [28].
Readmission and adherence/compliance were similar between telemedicine and nontelemedicine groups (Table 1) [15,
19, 27]. Costs were lower in the telemedicine groups, but based
on projections that may not be generalizable [15, 24, 28, 29].
Antibiotic use was similar between telemedicine groups and
controls [25, 27, 30–32].
DISCUSSION

Based on the available, albeit limited, evidence, telemedicine
ID consultation seems comparable to standard of care for the
Telemedicine ID Consultation • ofid • 3
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in 3 categories —Selection (maximum 4 stars), Comparability
(maximum 2 stars), and Outcome (maximum 3 stars)—with
a maximum score of 9 stars [13]. The quality of case–control
and cohort studies was adjudicated based on previously published guidance [14]: good quality: Selection ≥3 stars AND
Comparability ≥1 stars AND Outcome ≥2 stars; fair quality:
Selection 2 stars AND Comparability ≥1 stars AND Outcome
≥2 stars; poor quality: Selection ≤1 Star OR Comparability 0
stars OR ≤1 stars.

Table 1.

Clinical Outcomes of Telemedicine Infectious Diseases Consultation as Compared With Control for Individual Studies From Systematic Review

Study (First Author, Reference Number)

Control

Intervention

Group Size (Control, Intervention)

Telehealth Type

Mortality, %
Assimacopoulos [35]

5

1

59, 48

Chen [15]

1

0

150, 148

Face-to-face video

Saunderson [26]

12

22

294, 183

Telephone only

Monkowski [27]

10

5

73, 171

Face-to-face video

17

11

73, 171

Face-to-face video

Cuadrado [23]

n/a

Unable to determine

0, 63

Face-to-face video

Garrett [17]

n/a

100

0, 28

Telephone only

Telephone only

Monkowski [27]
Patient satisfaction, %

Leόn [16]

n/a

69

41, 42

Face-to-face video

Mashru [21]

n/a

98

0, 76

Face-to-face video

Nazareth [18]

n/a

100

559, 50

Face-to-face video

Saifu [19]

n/a

97

0, 43

Face-to-face video

You [20]

n/a

100

0, 96

Face-to-face video

Eron [24]

n/a

Unable to determine

25, 25

Face-to-face video

Staicu [22]

n/a

98

0, 50

Face-to-face video

Antimicrobial use, %
Mehrotra [30]

77

99

7545, 574

Rincon [31]

n/a

74

0, 5437

Shi [32]

53

52

1128629, 38839

Chen [15]

88

95

150, 148

Saifu [19]

n/a

76

0, 43

Face-to-face video
Other
Face-to-face video

Patient adherence/compliance, %
Telephone only
Face-to-face video

Length of hospital stay, d
Assimacopoulos [35]

10.7

6.5

59, 48

Ceradini [28]

8.4

8.4

683, 531

Face-to-face video
Physician-to-physician

Saunderson [26]

29

30

294, 183

Eron [24]

8

2.6

25, 25

Face-to-face video

Telephone only

Monkowski [27]

14

9

73, 171

Face-to-face video

13.4

6.9

59, 48

Face-to-face video

19

15

73, 171

Face-to-face video

Antimicrobial use, d
Assimacopoulos [35]
Monkowski [27]

clinical outcomes of mortality, length of stay, readmission, adherence, cost, and antimicrobial use. However, there were few
relevant studies tracking our prespecified clinical outcomes,
and the majority were of poor quality. Without more robust
data quality and availability, it is difficult to draw any firm
conclusions.
Few studies have been published demonstrating effectiveness
of telemedicine for infectious diseases consultation. Infection
types that have been studied, as well as the settings in which
telemedicine has been used, have been varied. As telemedicine
continues to expand, clinicians and researchers should consider
publication of their already existing data to document the clinical effectiveness needed to validate this model of care and costs.
In addition, researchers must report their processes of telemedicine ID implementation so that what works in 1 study can be
applied more broadly, understanding that adaptations will likely
be required. In this rapidly blossoming field, we must publish
best practices using standardized reporting for effective and
implementable telemedicine ID consults so that our patients
reap maximum benefits.
4 • ofid • Burnham et al

Our review is limited in scope by our chosen clinical outcomes. Among the excluded studies (data not shown) were
studies looking at the use of telemedicine to care for patients
with hepatitis C or HIV (among others). These studies are important and relevant to the telemedicine ID consultation landscape, but did not track our prespecified clinical outcomes. The
clinical outcomes we chose are of interest to inpatient settings
(mortality, readmission, length of stay) and administrators
(cost, patient satisfaction, readmission, antimicrobial use, mortality). A summary of the currently available data may help in
the adoption of inpatient telemedicine ID services by inpatient
physicians and administrators, should the data become more
robust.
Infectious diseases consultation can save lives, and with almost half of US hospitals without ID physician access [2], telemedicine has great potential to fill this gap. Before its wide
adoption, it should be robustly evidence-based. Important
questions in this arena are related to which type of telemedicine is required, how frequently telemedicine visits must be
performed (eg, daily, 1-time), and what level of infectious

Downloaded from https://academic.oup.com/ofid/article-abstract/6/12/ofz517/5658639 by Washington University at St Louis user on 04 January 2020

Readmission, %

Supplementary Data
Supplementary materials are available at Open Forum Infectious Diseases
online. Consisting of data provided by the authors to benefit the reader,
the posted materials are not copyedited and are the sole responsibility of
the authors, so questions or comments should be addressed to the corresponding author.
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diseases physician involvement is optimal to achieve the best
clinical outcomes. For example, a recent study showed that an
algorithm-based care model for Staphylococcus aureus bacteremia achieved noninferior outcomes to usual care [33]. With
this in mind, one must ask what the minimum unit of efficacy
is for infection management. Whether that is in-person consultation, telemedicine consultation, Extension for Community
Healthcare Outcomes (ECHO)–like models, algorithm-based
care, or another care model has yet to be determined. In addition, it is unknown whether certain infections will require
different levels of ID input for optimal outcomes. Notably, curbside consultations are often inaccurate and potentially harmful
[34], which may have implications for care delivery methods
(eg, telephone consultation only). Further studies are required.
Many questions remain to be answered for telemedicine ID consultation, including reimbursement, as state-to-state differences in
telemedicine coverage remain a barrier to implementation. As the
field of telemedicine continues to grow, these questions must be
addressed to provide the best and most efficient care for patients.
Societal and technological barriers such as access to high-speed
Internet and video quality have limited telemedicine’s usefulness
in the past. Although Internet access issues persist in some rural
areas, progress has been made and video quality has improved.
High-priority areas of telemedicine research include publishing
data that are already being collected as part of routine clinical care,
understanding the use of telemedicine in rural/underserved settings and how it reduces barriers to care and reduces the health
care disparities therein, and determining how to most efficiently
deliver care (eg, face-to-face vs e-consult, etc.). Telemedicine ID
consultation may be a way to reduce inequities and treatment disparities for rural/economically disadvantaged patients, and from
the perspective of primum non nocere, we must be sure that what
we are doing is what is best.
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